Insilico Drug Prediction and Validation of Lead candidates on Plasmodium falciparum Erythrocyte Membrane Protein 1(pfEMP1) against Malaria
Malaria is an infectious disease caused by protozoan of the genus Plasmodium. It is transmitted by bite from infected female Anopheles mosquito. Plasmodium falciparum erythrocyte membrane protein 1 (PfEmp1), an antigen that is responsible for the immune evasion of the protozoan. This protein has adhesive properties that cause the infected erythrocytes to bind to the endothelial lining of the blood vessel, thus preventing the infected cells from getting filtered by the spleen. It is found that there is an interaction between the sulphate ion on the endothelial cells and NH1, NH2 of Arg 1467 (A), NZ of Lys 1324 (A) and two bonds with N of Gly 1329 (A) on the protein. Inhibiting this interaction may prevent the evasive action. A Ligand with SO4 interactive region can be used to achieve this. Computer aided drug designing techniques were used to find a new scaffold to solve the purpose. GROMACS was used to simulate the protein-Ligand interaction. It was observed that ZINC17206599 shows the best interaction and may prove to be a promising candidate drug for Malaria.
Kirsten Flick, Qijun Chen (March 2004) 'var genes, PfEMP1 and the human host.', Molecular and Biochemical Parasitology, 134(1), pp.
'Malaria - Key Facts, World Health Organization',, (), pp.
Nordqvist, C. (2013, October 10) 'What Is Malaria? Medical News Today.', , (), pp.
Joseph D. Smith,1,2* J. Alexandra Rowe,3 Matthew K. Higgins4 and Thomas Lavstsen5 (2013) 'Malaria’s deadly grip: cytoadhesion of Plasmodium falciparum-infected erythrocytes', Cellular Microbiology, (), pp.
Noa D. Pasternak, Ron Dzikowski. PfEMP1: An antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum. The International Journal of Biochemistry & Cell Biology 41 (2009) 1463–1466.
Qijun Chen,* Antonio Barragan,* Victor Fernandez,*Annika Sundström,* Martha Schlichtherle,* Anders Sahlén,*Johan Carlson,* Santanu Datta, ‡ and Mats Wahlgren*.Identification of Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) as the Rosetting Ligand of the Malaria Parasite P. falciparum. Volume 187, Number 1, January 5, 1998 15–23. (http://www.jem.org).
Susan M Kraemer1 and Joseph D Smith1, 2. A family affair: var genes, PfEMP1 binding, and malaria disease. Current Opinion in Microbiology 2006, 9:374–380
F. A. Ng’ong’a, J. K. Ng’ang’a, D. Kariuki and J. K. Kinyua (n.d.) 'COMPUTER ASSISTED DRUG DESIGN (CADD) AGAINST PLASMODIUM FALCIPARUM', , (), pp.
Suri Moonsamy • Mahmoud E. S. Soliman (4 June 2013) 'Dual acting HIV inhibitors: integrated rational in silico design strategy', Med Chem Res, (), pp.
D I Baruch, J A Gormely, C Ma, R J Howard, and B L Pasloske. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. Apr 16, 1996; 93(8): 3497–3502.
Chinwe Ekenna, Segun Fatumo and Ezekiel Adebiyi (2010) 'In-silico evaluation of malaria drug targets', IACSIT International Journal of Engineering and Technology, 2(ISSN 1793-8236), pp.
Talleh Almelli1,2, Nicaise T Ndam1,2, Sem Ezimegnon3, Maroufou J Alao4, Charles Ahouansou3, Gratien Sagbo5, Annick Amoussou6, Philippe Deloron1,2 and Rachida Tahar1,2* (2014) 'Cytoadherence phenotype of Plasmodium falciparum-infected erythrocytes is associated with specific pfemp-1 expression in parasites from children with cerebral malaria', Malaria Journal, (), pp.
E.N BHARATH*, S.N MANJULA, A. VIJAYCHAND (2011) 'IN SILICO DRUG DESIGNTOOL FOR OVERCOMING THE INNOVATION DEFICIT IN THE DRUG DISCOVERY PROCESS', International Journal of Pharmacy and Pharmaceutical Sciences, 3(ISSN- 0975-1491), pp.